Follow
Kanmin Xue
Title
Cited by
Cited by
Year
Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR
J Cehajic-Kapetanovic, K Xue, C Martinez-Fernandez de la Camara, ...
Nature medicine 26 (3), 354-359, 2020
2542020
Visual acuity after retinal gene therapy for choroideremia
TL Edwards, JK Jolly, M Groppe, AR Barnard, CL Cottriall, T Tolmachova, ...
New England Journal of Medicine 374 (20), 1996-1998, 2016
2242016
The in vivo pattern of AID targeting to immunoglobulin switch regions deduced from mutation spectra in msh2−/− ung−/− mice
K Xue, C Rada, MS Neuberger
The Journal of experimental medicine 203 (9), 2085-2094, 2006
2082006
First-in-human study of the safety and viability of intraocular robotic surgery
TL Edwards, K Xue, HCM Meenink, MJ Beelen, GJL Naus, MP Simunovic, ...
Nature biomedical engineering 2 (9), 649-656, 2018
1932018
Assessment of the electronic retinal implant alpha AMS in restoring vision to blind patients with end-stage retinitis pigmentosa
TL Edwards, CL Cottriall, K Xue, MP Simunovic, JD Ramsden, E Zrenner, ...
Ophthalmology 125 (3), 432-443, 2018
1822018
Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia
K Xue, JK Jolly, AR Barnard, A Rudenko, AP Salvetti, MI Patrício, ...
Nature medicine 24 (10), 1507-1512, 2018
1802018
Technique of retinal gene therapy: delivery of viral vector into the subretinal space
K Xue, M Groppe, AP Salvetti, RE MacLaren
Eye 31 (9), 1308-1316, 2017
1702017
Interaction between antibody-diversification enzyme AID and spliceosome-associated factor CTNNBL1
SG Conticello, K Ganesh, K Xue, M Lu, C Rada, MS Neuberger
Molecular cell 31 (4), 474-484, 2008
1662008
Deep-learning models for the detection and incidence prediction of chronic kidney disease and type 2 diabetes from retinal fundus images
K Zhang, X Liu, J Xu, J Yuan, W Cai, T Chen, K Wang, Y Gao, S Nie, X Xu, ...
Nature biomedical engineering 5 (6), 533-545, 2021
1642021
Current status and future trends of clinical diagnoses via image-based deep learning
J Xu, K Xue, K Zhang
Theranostics 9 (25), 7556, 2019
962019
Characterizing the natural history of visual function in choroideremia using microperimetry and multimodal retinal imaging
JK Jolly, K Xue, TL Edwards, M Groppe, RE MacLaren
Investigative ophthalmology & visual science 58 (12), 5575-5583, 2017
912017
The spectrum of CHM gene mutations in choroideremia and their relationship to clinical phenotype
MP Simunovic, JK Jolly, K Xue, TL Edwards, M Groppe, SM Downes, ...
Investigative ophthalmology & visual science 57 (14), 6033-6039, 2016
812016
Correlation of optical coherence tomography and autofluorescence in the outer retina and choroid of patients with choroideremia
K Xue, M Oldani, JK Jolly, TL Edwards, M Groppe, SM Downes, ...
Investigative Ophthalmology & Visual Science 57 (8), 3674-3684, 2016
812016
A deep-learning system predicts glaucoma incidence and progression using retinal photographs
F Li, Y Su, F Lin, Z Li, Y Song, S Nie, J Xu, L Chen, S Chen, H Li, K Xue, ...
The Journal of Clinical Investigation 132 (11), 2022
562022
Antisense oligonucleotide therapeutics in clinical trials for the treatment of inherited retinal diseases
K Xue, RE MacLaren
Expert Opinion on Investigational Drugs 29 (10), 1163-1170, 2020
562020
Structural and functional recovery following limited iatrogenic macular detachment for retinal gene therapy
MP Simunovic, K Xue, JK Jolly, RE MacLaren
JAMA ophthalmology 135 (3), 234-241, 2017
492017
Meta-analysis of the adjunctive use of mitomycin C in primary and revision, external and endonasal dacryocystorhinostomy
K Xue, FE Mellington, JH Norris
Orbit 33 (4), 239-244, 2014
452014
Immunomodulatory effects of hydroxychloroquine and chloroquine in viral infections and their potential application in retinal gene therapy
LC Chandler, IH Yusuf, ME McClements, AR Barnard, RE MacLaren, ...
International journal of molecular sciences 21 (14), 4972, 2020
422020
Deep periocular infantile capillary hemangiomas responding to topical application of timolol maleate, 0.5%, drops
K Xue, GD Hildebrand
JAMA ophthalmology 131 (9), 1246-1248, 2013
412013
A network meta-analysis of retreatment rates following bevacizumab, ranibizumab, aflibercept, and laser for retinopathy of prematurity
E Chang, AS Josan, R Purohit, CK Patel, K Xue
Ophthalmology 129 (12), 1389-1401, 2022
382022
The system can't perform the operation now. Try again later.
Articles 1–20